For instance, we previously found miR-34a to be devoid in prostate cancer stem cell (PCSC) populations (e.g., those identified as CD44+/hi), and overexpression of miR-34a induced pronounced inhibitory effects on tumor growth and metastasis in vivo by negatively regulating PCSCs (Liu et al., 2011). Here, CD44 is linked to neoplasm.